Investor's Business Daily on MSN23m
ARS Pharma Retakes Its 50-Day Line In Bullish Post-Earnings Move. Here's Why.Shares of ARS Pharmaceuticals bounded higher Thursday after the company reported an unexpected fourth-quarter metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback